Strategic partnership Eloquest Healthcare has a proven channel strategy through a strategic partnership with InterRad Medical to expand U.S. sales of SecurAcath, presenting a ready-made entry point for pursuing hospital accounts and clinician education programs focused on device securement and infection prevention.

Clinical value focus The company emphasizes evidence-backed solutions that improve patient outcomes and clinician efficiency, highlighting opportunities to position Eloquest products as cost-saving, workflow-friendly options within hospital supply chains and infection control initiatives.

Product portfolio leverage With established brands like Mastisol and Detachol forming its core, there is potential to upsell or bundle related skin integrity, adhesive, and dressing-change reduction offerings to current accounts seeking comprehensive skin care and dressing protocols.

Growth and funding signals Revenue in the multi‑million range and recent collaboration for market expansion suggest a growth trajectory, making the company a target for strategic distributors, analytics tools, and clinical education partners to broaden market reach.

Market positioning Operating in medical equipment manufacturing with a focus on adoption in real-world clinical settings, Eloquest presents opportunities to engage hospital procurement, OR managers, and infection prevention teams seeking reliable, evidence-supported solutions that reduce variability and total cost of care.